In some ways, the Drug Enforcement Agency’s (DEA) proposed rules for prescribing controlled substances via telemedicine are a sign of progress. Behavioral health could be getting some much-needed clarity, but at what cost?
The new DEA ruling is doing a disservice not only to people with OUD, but to the entire medical care system—exacerbating a condition that will most likely lead to death.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
A hospital corporation with facilities across Massachusetts must pay $1.9 million in civil penalties in a lawsuit alleging that an employee stole more than 17,000 units of controlled substances and the hospitals did not have accurate records of controlled substances to prevent such illegal activity.